Abbreviations used: AID, activation-induced cytidine deaminase; BMDC, BM-derived DC; dsDNA, double-stranded DNA; MAP, multiple antigenic peptide.
B cells responding to antigen in a T cell -dependent response can be activated to become shortlived plasma cells with no memory capabilities, or germinal center cells, which mature to become either long-lived plasma cells or memory B cells. The nature of the antibody-producing cell infl uences the duration of the antibody response as well as the affi nity and isotype of the antibody that is made, all of which constitute important parameters of protective immunity. The phenotype of the autoreactive B cell producing the autoantibody in patients with autoimmune disease may also infl uence both the pathogenicity of the autoantibody and the response to therapy. Antibody responses that include a memory cell compartment may be important in protective immunity, but as autoantibody responses they may be more diffi cult to eradicate. Thus, understanding the conditions that lead to the generation of either short-lived plasma cells or long-lived plasma cells and memory cells may be of considerable clinical importance.
We have previously described a model of antigen-induced autoimmunity in which we can examine the inductive phase of the autoreactive humoral response. BALB/c mice immunized with a peptide mimotope of double-stranded DNA (dsDNA) will develop antibodies that are cross-reactive with dsDNA and peptide. These antibodies deposit in renal glomeruli and cause proteinuria. Because there is minimal cellular infi ltrate in the kidney, probably because of a lack of renal vulnerability to antibody-mediated disease in this strain, the model is one of nephrotic syndrome ( 1 ) . The autoantibody response in these mice is T cell -dependent, with antigenspecifi c T cells producing Th1 cytokines on antigen challenge ( 2 ) .
Our understanding of the immunological function of ␥ chain -associated FcRs has been facilitated by studies from Takai et al. ( 3 ) on FcR-associated ␥ chain -null mice (Fc ␥ Ϫ / Ϫ ). The Fc ␥ Ϫ / Ϫ mice have a selective defect in the expression of FcRs on the cell surface as well as in the FcR-mediated signal cascade. Interestingly, disruption of the FcR ␥ chain in NZB/ signifi cantly more glomerular IgG deposition than WT kidneys, and the mice displayed increased proteinuria ( Fig. 1 c ) . Thus, the antibodies from Fc ␥ Ϫ / Ϫ mice, although of lower affi nity than the antibodies in WT mice, were still of suffi cient affi nity to cause glomerular dysfunction. This observation is NZW mice uncouples immune complex formation from the infl ammatory response in the kidney, implying a pathogenic role of FcR ␥ chain in autoimmune disease ( 4 ) .
There are several factors involved in determining the phenotype of antigen-experienced B cells, including BCR signal strength ( 5 ) , expression of transcription factors ( 6 ) , and costimulatory infl uences ( 7 -9 ) . In the course of studying renal pathology in peptide-immunized mice defi cient in the FcR ␥ chain (Fc ␥ Ϫ / Ϫ ), we made the surprising observation that Fc ␥ Ϫ / Ϫ mice preferentially develop short-lived plasma cells and fail to develop a germinal center response. We show that this altered B cell response is a consequence of increased IL-12 production by DCs.
RESULTS

Fc ␥ ؊ / ؊ mice display a distinct humoral response to antigen
Immunization of BALB/c mice with a peptide mimotope of dsDNA, DWEYSVWLSN, octamerized on a polylysine backbone (multiple antigenic peptide [MAP] peptide) induces antibodies that cross-react with peptide and dsDNA ( 1 ) . We immunized Fc ␥ Ϫ / Ϫ and WT mice i.p. with MAP peptide in CFA and boosted with antigen in IFA on days 7 and 14. By day 28, Fc ␥ Ϫ / Ϫ mice generated signifi cantly higher serum titers of both antipeptide (approximately fi vefold) and anti-dsDNA antibody (approximately sevenfold; Fig. 1 a ) . The diff erence in serum antibody reactivity did not refl ect a diff erence in the kinetics of the response, as both strains exhibited a similar timing of antibody production ( Fig. 1 a ) . An antigen-specifi c IgM response was induced in WT and Fc ␥ Ϫ / Ϫ mice. Consistent with the IgG response, there was a higher IgM response in Fc ␥ Ϫ / Ϫ mice at week 2, but this declined to the basal level by week 4 in both strains (Fig. S1 , available at http://www .jem.org/cgi/content/full/jem.20070731/DC1).
One explanation for the greater IgG serum reactivity in Fc ␥ Ϫ / Ϫ mice would be an increased affi nity of antipeptide antibodies. We, therefore, performed inhibition ELISAs with soluble peptide and calculated apparent affi nities by determining the molar concentration of soluble antigen that led to 50% inhibition of the antibody reactivity ( 10 ) . Contrary to our initial expectation, antipeptide antibodies from Fc ␥ Ϫ / Ϫ mice had a log lower apparent affi nity than antipeptide antibodies from WT mice (1.4 × 10 5 vs. 2.2 × 10 6 ; P ≤ 0.01), demonstrating that the increased titers resulted from the production of more antigen-specifi c antibody.
Furthermore, although IgG1 was the predominant isotype observed in both the antipeptide and anti-dsDNA response in WT mice, Fc ␥ Ϫ / Ϫ mice produced both IgG1 and IgG2a antipeptide ( Fig. 1 b ) and anti-dsDNA antibodies (not depicted). This did not refl ect an intrinsic bias toward increased IgG2a, as the isotype distribution for total serum IgG was similar in both mouse strains (not depicted).
Because the diff erence in antibody titer between strains was ‫ف‬ 5 -10-fold, we believed it was important to ask whether this increase in serum antibody titer might be of pathological signifi cance. Kidneys from MAP peptide -immunized Fc ␥ Ϫ / Ϫ mice, analyzed 13 wk after the initial antigen challenge, had (a) Fc ␥ Ϫ / Ϫ (gray triangles) and WT (black squares) mice ( n = 5 in each group) were immunized with 100 μ g MAP peptide and boosted twice (arrows indicate time of boosts). Serum was collected on days 0, 14, 28, 42, and 56, and antipeptide and anti-dsDNA IgG ELISAs were performed. P ≤ 0.05 in both graphs. (b) Mice were immunized as described in a. 7-wk serum was assayed for isotype-specifi c antipeptide antibody ELISAs. Titrations were twofold and began at the dilution indicated on the x-axis. Gray triangles show Fc ␥ Ϫ / Ϫ mice and black squares show WT mice. IgG1, P = 0.02; IgG2a, P = 0.048. n = 5. (c) Kidneys were taken at day 91, and sections were stained for IgG deposition. Sections shown above are representative of fi ve mice in each group. Sections were magnifi ed 100 × . Bars, 50 μ m. 50 glomeruli were counted in each kidney section, and the percent positive for IgG deposition was graphed. *, P ≤ 0.05. Proteinuria was determined by measuring the amount of protein in the urine of mice at day 91 after immunization. (d) Both WT and Fc ␥ Ϫ / Ϫ mice were immunized with 100 μ g MAP peptide in CFA on day 0 and boosted on day 7 with MAP peptide in IFA. On day 56, mice were challenged with 100 μ g MAP peptide in IFA, and serum was collected 5 d after challenge. Antipeptide ELISAs were performed. P ≤ 0.05. (e) WT and Fc ␥ Ϫ / Ϫ mice (fi ve in each group) were immunized with 100 μ g 10 -2 -BSA and boosted twice. Day-0, -14, -28, and -42 serum was assayed by ELISA for anti -10-2 IgG. P ≤ 0.05. Data are presented as mean ± SD.
Differential humoral response in Fc ␥ ؊ / ؊ mice is not determined by B cells
The increased antipeptide and anti-DNA response in Fc ␥ Ϫ / Ϫ mice might refl ect either a B cell -intrinsic phenotype or, alternatively, a diff erent response to immunization in non-B cells. To test whether the diff erence was B cell intrinsic, splenic B cells from WT or Fc ␥ Ϫ / Ϫ mice were transferred to B celldefi cient BALB/c mice (muMT). Both WT B cell -reconstituted and Fc ␥ Ϫ / Ϫ B cell -reconstituted muMT mice were immunized with MAP peptide. As shown in Fig. 2 , there was no statistically signifi cant diff erence in serum antipeptide response between WT and Fc ␥ Ϫ / Ϫ B cell -reconstituted mice. Moreover, analysis of splenic B cell subsets (mature vs. immature and transitional vs. follicular vs. marginal zone) confi rmed that there was no diff erence in B cell diff erentiation between Fc ␥ Ϫ / Ϫ and WT BALB/c B cells. The expression of several cell surface markers (CD22, CD40, CD43, CD79b, CD27, MHC II, Fas, CD80, and CD86) also was not diff erent between Fc ␥ Ϫ / Ϫ and WT BALB/c B cells. B cell function, assayed by IgM-mediated apoptosis and B cell proliferation to anti-IgM plus anti-CD40 antibody or anti-CD40 antibody plus IL-4, was also similar between both strains (unpublished data). Thus, the phenotype and function of naive B cells of both strains were indistinguishable.
Fc ␥ ؊ / ؊ B cells preferentially differentiate into short-lived plasma cells Because the antibody response in Fc ␥ Ϫ / Ϫ mice was of low affi nity and the memory response was impaired, we hypothesized that there was a defect in germinal center maturation, which generates both memory B cells and long-lived plasma cells, and a preferential generation of short-lived plasma cells ( 13 -16 ) . Short-lived plasma cells develop in T cell -dependent responses but do not display affi nity maturation and are not associated with a clonally related memory B cell population ( 17, 18 ) . After activation with antigen, short-lived plasma cells reside primarily in the extrafollicular foci of the spleen, whereas long-lived plasma cells preferentially migrate to the BM ( 16 -19 ) . First, we determined the number of antibody-secreting cells (including plasmablasts, short-lived plasma cells, and long-lived plasma cells) in the spleen. There was a higher percentage of B220 lo and CD138 + cells in the B cell population in MAP peptide -immunized Fc ␥ Ϫ / Ϫ mice compared with WT mice on day 8 ( Fig. 3 a ) . To determine the location of B220 lo and CD138 + cells within the spleen, immunohistochemistry was performed on spleens of immunized mice. The majority of CD138 + cells were positioned outside the B cell follicles where short-lived plasma cells reside ( Fig. 3 b ) . CD138 + cells colocalized with kappa chain positivity but not with CD4 positivity (unpublished data). To confi rm this observation, we also performed peptide-specifi c ELISPOT assays of splenic B cells. Fig. 3 c shows that 2.5-fold more cells secreting specifi c antibody were present in spleens of Fc ␥ Ϫ / Ϫ mice than in WT spleens. By day 28, splenic plasma cells from both Fc ␥ Ϫ / Ϫ and WT mice declined in number, presumably because of apoptosis of short-lived plasma cells. consistent with clinical experience where a four-to eightfold increase in autoantibody titer may correlate with the onset of disease or with increased disease activity. For example, an antinuclear antibody titer of 1:40 is normal, whereas an eightfold increase to 1:320 is highly signifi cant for disease. Likewise, a four to eightfold increase in anti-DNA antibody titer in a patient with SLE will often precede a clinical fl are ( 11 ) .
High affi nity antibody responses are generated by a germinal center reaction in which B cells undergo somatic hypermutation and there is selection for survival of B cells making the highest affi nity antibodies. These cells mature to become long-lived plasma cells and memory cells. To determine if the lack of a high affi nity antibody response refl ected a failure of B cells to undergo germinal center maturation, we questioned whether Fc ␥ Ϫ / Ϫ mice developed a memory response. WT and Fc ␥ Ϫ / Ϫ mice were immunized and boosted with MAP peptide. 8 wk later, mice were challenged with 100 μ g MAP peptide. 5 d later, blood was collected to measure the antipeptide response in serum. Fig. 1 d shows that WT mice have a rapid increase in the serum antipeptide response, which was not observed in Fc ␥ Ϫ / Ϫ mice. These data suggest a signifi cant reduction in the population of memory B cells in Fc ␥ Ϫ / Ϫ mice.
To determine whether Fc ␥ Ϫ / Ϫ mice immunized with a nonself antigen would also develop an enhanced serum response, we examined the response of Fc ␥ Ϫ / Ϫ mice to 10 -2, a peptide mimotope of phosphorylcholine, conjugated to BSA ( 12 ) . As seen in Fig. 1 e , Fc ␥ Ϫ / Ϫ mice made signifi cantly more anti -10-2 antibodies (an approximately threefold increase in titer) than WT mice. In addition, although WT mice made predominantly IgG1 anti -10-2 antibodies, Fc ␥ Ϫ / Ϫ mice also produced antigen-specifi c IgG2a antibodies (unpublished data). Thus, the strain-specifi c diff erence in antibody response was not limited to an autoreactive response. These results were consistent with the preferential generation of short-lived plasma cells in Fc ␥ Ϫ / Ϫ mice in contrast to the predominance of long-lived plasma cells present in the BM of WT mice.
Because the antipeptide antibody response was previously shown to be a T cell -dependent response in WT mice ( 2 ), we questioned whether the antibody response in Fc ␥ Ϫ / Ϫ mice was also T cell dependent, as it displayed less evidence of germinal center formation. Fig. 4 a shows that antibody generation is abolished in CD4 T cell -depleted mice. Thus, the diminished germinal center response is not caused by an absent T cell response.
Antigen-specifi c T cells are activated by MAP peptide immunization in Fc ␥ Ϫ / Ϫ mice. To demonstrate T cell activation in Fc ␥ Ϫ / Ϫ mice, we assessed antigen-specifi c proliferation of T cells from MAP peptide -immunized mice. T cells from MAP peptide -immunized Fc ␥ Ϫ / Ϫ and WT mice proliferated in response to antigen ( Fig. 4 b ) . In fact, the response of T cells from Fc ␥ Ϫ / Ϫ T cells was greater than that of WT T cells. To ascertain whether this enhanced T cell response refl ected a change in T cell repertoire, we assessed V ␤ usage. Fig. 4 c shows that there was no signifi cant diff erence in TCR V ␤ chain usage between WT and Fc ␥ Ϫ / Ϫ mice, either before or after MAP peptide immunization. Furthermore, antigen-specifi c T cells from both strains produced IL-2 and IFN-␥ (unpublished data). These data demonstrate that T cells in Fc ␥ Ϫ / Ϫ mice were activated to at least the same extent as T cells from WT mice after MAP peptide immunization. Thus, the altered antibody response is not a consequence of a failure of T cell priming.
Fc ␥ ؊ / ؊ mice display a diminished germinal center response To demonstrate directly that Fc ␥ Ϫ / Ϫ mice display reduced germinal center maturation of B cells, we asked whether the reduced affi nity of serum antibodies in Fc ␥ Ϫ / Ϫ mice refl ected a relative lack of somatic hypermutation occurring in the Fc ␥ Ϫ / Ϫ mice, as somatic hypermutation is a feature of the germinal center response and a critical contribution to affi nity maturation. To address this question, we generated antigenspecifi c hybridomas from WT and Fc ␥ Ϫ / Ϫ mice immunized with MAP peptide. We examined the number of mutations in the region downstream of the rearranged J H in B cells making antipeptide antibody. We chose to enumerate mutations in this region because it has been shown to undergo hypermutation. Because it is not a coding region, it is not subject to the pressures of selection. As seen in Fig. 5 a , hybridomas from Fc ␥ Ϫ / Ϫ mice had many fewer mutations. Splenic histology displayed fewer germinal centers in Fc ␥ Ϫ / Ϫ mice after immunization ( Fig. 5 b ) . This was confi rmed by quantifi cation of B220 + PNA + cells in the spleen (Table  S1 , available at http://www.jem.org/cgi/content/full/jem .20070731/DC1). There were very few PNA + cells in the B220 + population in Fc ␥ Ϫ / Ϫ mice on days 8 and 16 after immunization compared with WT mice ( Fig. 5 c ) . We also measured activation-induced cytidine deaminase (AID) induction in germinal center B lymphocytes because expression Long-lived plasma cells migrate to the BM, where they secrete antibody. To determine whether long-lived plasma cells were being generated in Fc ␥ Ϫ / Ϫ mice, we enumerated plasma cells by peptide-specifi c ELISPOT assays in the BM. Plasma cells were detectable in the BM between days 21 and 35 after the initial immunization. Fc ␥ Ϫ / Ϫ mice had 5.3-fold fewer peptide-specifi c plasma cells in the BM on day 35 ( Fig. 3 d ) . of AID is suppressed in mature B cells and only expressed in germinal center B cells ( 20 ) . WT mice display a signifi cant induction of AID in germinal center B cells. Fc ␥ Ϫ / Ϫ mice, however, did not show any signifi cant induction of AID, which is consistent with a diminished germinal center reaction in these mice ( Fig. 5 d ) . These studies all support a reduced germinal center response in Fc ␥ Ϫ / Ϫ mice. have shown that DCs can induce naive B cells to proliferate in an IL-12 -dependent manner. We therefore examined whether BM-derived DCs (BMDCs) from Fc ␥ Ϫ / Ϫ mice were more potent producers of IL-12 and stimulators of B cell proliferation. IL-12 was measured in immature and LPS-matured BMDCs by intracellular fl ow cytometry and cytokine ELISA. Flow cytometry, which measured IL-12 p40, demonstrated a twofold increase in the number of DCs producing IL-12 in Fc ␥ Ϫ / Ϫ mice ( Fig. 6 a ) . A cytokine ELISA for IL-12 p40/70 detected IL-12 production only by LPS-stimulated BMDCs and confi rmed a two-to threefold increase in production by Fc ␥ Ϫ / Ϫ DCs ( Fig. 6 b ) . Real-time PCR also demonstrated increased induction of IL-12p35 and p40 in LPS-stimulated BMDC from Fc ␥ Ϫ / Ϫ mice ( Fig. 6 c ) . Fc ␥ Ϫ / Ϫ BMDCs also displayed signifi cantly higher expression of MHC II, CD80, and CD86 than WT BMDCs (Fig. S2 , available at http:// www.jem.org/cgi/content/full/jem.20070731/DC1). Finally, we measured IL-12 expression in splenic DCs after MAP peptide immunization in vivo. Both WT and Fc ␥ Ϫ / Ϫ mice were immunized. On days 1 and 3, total splenic DCs were purifi ed and further cultured for 16 h to permit cytokine secretion. Fig. 6 d demonstrates that splenic DCs from Fc ␥ Ϫ / Ϫ mice expressed about twofold more IL-12 than DCs from WT mice by day 3.
Because there are other cell types that can produce IL-12 upon activation, we measured production of IL-12 by macrophages and B cells. As seen in previous studies, LPS stimulation strongly induced production of IL-12 from peritoneal macrophages, but there was no diff erence between WT and Fc ␥ Ϫ / Ϫ macrophages. B cells from WT and Fc ␥ Ϫ / Ϫ mice also produced equal amounts of IL-12 p40 after upon LPS and LPS plus anti-CD40 antibody stimulation. ( Fig. 6 e ) .
To confi rm that the increased IL-12 could lead to an expanded B cell population, naive WT B cells were cultured with anti-CD40 antibody and irradiated BMDCs from either Fc ␥ Ϫ / Ϫ or WT mice. After 5 d in culture, B cells proliferated in the presence of Fc ␥ Ϫ / Ϫ BMDCs, whereas little or no BMDC-dependent proliferation was seen in the presence of WT BMDCs ( Fig. 7 a ) . Furthermore, when a neutralizing anti -IL-12 antibody was added at the beginning of the culture, B cell proliferation driven by Fc ␥ Ϫ / Ϫ BMDCs decreased by as much as 80% ( Fig. 7 b ) . Because anti -IL-12 antibody recognizes both the p35 and the p40 subunits of IL-12 and p40 is also a subunit of IL-23, there is a possibility of inhibition of both cytokines by the anti -IL-12 antibody. To address this problem, IL-12a (p35) -specifi c siRNA was used. Transfection effi ciency was determined and specifi city of IL-12a siRNA was confi rmed using control siRNA and analyzing gene expression of IL-12b (Fig. S3 , available at http://www.jem.org/cgi/content/full/ jem.20070731/DC1). Consistent with the results using anti -IL-12 antibody, IL-12a siRNA transfection of BMDCs abrogated the proliferation of B cells ( Fig. 7 c ) . The inhibition was specifi c, as transfection with control siRNA showed no significant reduction in B cell proliferation. Therefore, Fc ␥ Ϫ / Ϫ DCs are potent stimulators of B cell proliferation, and their stimulatory function depends largely on the production of IL-12. Mice were immunized as described previously and splenic DCs were purifi ed on days 1 and 3 after immunization. Cells were plated at 10 6 /ml in 24-well plates for 16 h. IL-12 in the supernatant was analyzed by ELISA. *, P ≤ 0.05 (mean ± SD of three individual mice). (e) Splenic B cells and peritoneal macrophages were isolated and the purity of the populations was determined as described in Materials and methods. For B cells, 10 6 cells/ml were plated in 24-well plates alone, with 5 μ g/ml of LPS, or with 5 μ g/ml LPS with 20 μ g/ml of activating anti-CD40 antibodies and incubated for 18 h. Supernatants were harvested and IL-12 p40 was measured as described. For macrophages, 10 6 cells/ml were cultured in 24-well plates with or without 2 μ g/ml LPS for 18 h. IL-12 p40 and p70 in the supernatant was measured by ELISA (mean ± SD of four individual mice).
Fc ␥ Ϫ / Ϫ .IL-12a +/ Ϫ mice. First, we examined the eff ect of IL-12 in WT, Fc ␥ Ϫ / Ϫ mice, or Fc ␥ Ϫ / Ϫ .IL-12a +/ Ϫ mice. The level of expression of IL-12 p35 assessed by real-time PCR showed decreases in both WT and Fc ␥ Ϫ / Ϫ .IL-12a +/ Ϫ mice compared with Fc ␥ Ϫ / Ϫ mice (Fig. S4 , available at http://www.jem.org/ cgi/content/full/jem.20070731/DC1). MAP peptide -immunized Fc ␥ Ϫ / Ϫ .IL-12a +/ Ϫ mice generated a low number of antipeptide antibody secreting cells in spleen, which is similar to WT mice ( Fig. 8 c ) , and a high number of plasma cells in the BM, which is also similar to WT mice ( Fig. 8 d ) . The enhanced B cell response of the Fc ␥ Ϫ / Ϫ mice can, therefore, be attributed, at least in part, to increased IL-12 production by DCs, as it is altered when IL-12 production is diminished.
DISCUSSION
Understanding mechanisms underlying the commitment to a particular B cell fate has clinical importance. Memory cells can proliferate extensively upon secondary challenge, and long-lived plasma cells can secrete antibody for long periods of time without antigen contact. Therefore, the prevalence of autoreactivity in the memory population may result in a chronic antibody-mediated disease. In contrast, short-lived plasma cells may generate large amounts of a pathogenic
IL-12 secretion infl uences the differentiation of plasma cells in vivo
To confi rm that the increased IL-12 production by DCs accounted for the altered antibody response seen in vivo in Fc ␥ Ϫ / Ϫ mice, we determined if WT mice given supplemental IL-12 would produce more plasma cells in spleen. WT mice were injected i.p. with 1 μ g of either soluble IL-12 or saline on days Ϫ 1, 0, and +1 of the immunization schedule. Antigen boosts were given with no additional IL-12. 11 d after the last boost, WT mice treated with IL-12 had approximately threefold more splenic antibody-secreting cells than untreated mice, which is similar to the diff erence observed in Fc ␥ Ϫ / Ϫ mice ( Fig. 8 a ) . IL-12 -treated WT mice also experienced an ‫ف‬ 35% decrease in BM plasma cells, which is also similar to Fc ␥ Ϫ / Ϫ mice ( Fig. 8 b ) . Thus, exogenous IL-12 caused WT mice to acquire a phenotype of antigen-specifi c B cells similar to that of Fc ␥ Ϫ / Ϫ mice. We confi rmed this observation in a study of These results are mean ± SD of three independent experiments. (c) A proliferation assay was performed with siRNA-transfected BMDCs. BMDCs were generated from WT mice and Fc ␥ Ϫ / Ϫ mice. 10 μ M of either anti -IL-12a or control siRNA was transfected, as described in Materials and methods, at day 7 of culture. The next day, siRNA-transfected and -untransfected DCs were incubated with 1 μ g/ml LPS to mature DCs. Proliferation assays were performed as described in Materials and methods. The results are mean ± SD of fi ve indivual mice. plasma cells, a pattern mimicking that seen in immunized Fc ␥ Ϫ / Ϫ mice. Therefore, IL-12 produced by DCs seems to be highly infl uential in directing B cell diff erentiation. It is possible that this diff erence in diff erentiation pathway refl ects a change in the environment in which the B cell resides rather than a direct eff ect on the B cell. We do not favor this explanation, as chemokine expression in the spleen is similar in both strains (Fig. S6 , available at http://www.jem.org/cgi/content/ full/jem.20070731/DC1). Furthermore, IL-12 has been shown by others to act directly on B cells ( 21 ) . Interestingly, CR2 (CD21/CD35) has also been reported to diminish the development of long-lived plasma cells while leaving intact the generation of short-lived plasmablasts, germinal center, and memory B cells. This eff ect is mediated through the regulation of Blimp-1 and XBP-1, which are critical transcription factors in plasma cell diff erentiation ( 29 ) . CR2, like FcR, appears to function through a B cell -intrinsic pathway that specifi cally arrests the diff erentiation of long-lived plasma cells. We should note, however, that antigen-specifi c T cell proliferation was enhanced in Fc ␥ Ϫ / Ϫ mice. The enhanced number of antigenspecifi c T cells expressing CD40L and available to interact with antigen-specifi c B cells may also contribute to the preferential generation of short-lived plasma cells. Thus, both the direct action of DCs on B cells as well as the action of T cells in Fc ␥ Ϫ / Ϫ mice may contribute to skewing the B cell response.
Although the diff erences in IL-12 production between the mouse strains may seem small, we have previously shown in studies of hormonal eff ects on B cells that a 20% change in expression of CD22 can aff ect B cell receptor signaling and alter negative selection ( 30 ) . Recently, McGaha et al. ( 31 ) have shown that a 50% increase in Fc ␥ RIIb expression in B cells can prevent disease in lupus-prone mice. Thus, it should not be surprising that a twofold increase in IL-12 production by DCs can aff ect B cell diff erentiation. In fact, a study of experimental myasthenia gravis in mice also demonstrated that exogenous IL-12 given in a similar protocol led to increased serum antibody ( 27 ) .
A previous study reported no alteration in humoral response to the hapten NP in Fc ␥ Ϫ / Ϫ mice. This study was performed on C57BL/6 mice defi cient in the FcR ␥ chain and may reveal a strain-dependent diff erence in FcR ␥ chain function. It is also possible, however, that the force of selection for high-affi nity antibodies in the NP model is so strong that diff erences in B cell diff erentiation were obscured. Some eff ects were seen that were similar to those we report. For example, in the reported study that Fc ␥ Ϫ / Ϫ mice had fewer splenic germinal centers after immunization.
We do not yet fully understand why the absence of the ␥ chain leads to the observed DC phenotype. Studies on ␥ chain -defi cient mice have focused on alterations in expression and function of FcRI, FcRIII, and FcRIV ( 32 ) . To confi rm that the serological changes were mediated through FcR engagement, we have immunized FcRIII-defi cient mice with MAP peptide. These mice show increased serum antipeptide antibodies (fi vefold increase) and an activated phenotype of BMDCs. Similarly, DCs derived from BM cells under antibody that, as shown in this study, does not necessarily need to be of the highest affi nity to cause organ damage.
Through the analysis of Fc ␥ Ϫ / Ϫ mice, we have demonstrated that DCs participate in determining B cell diff erentiation in vivo. Fc ␥ Ϫ / Ϫ B cells became predominantly splenic plasma cells upon activation instead of forming the more heterogeneous population of short-lived and long-lived plasma cells and memory cells seen in WT mice. Current data suggest that the majority of splenic plasma cells are short lived, whereas plasma cells in the BM can be either short lived or long lived ( 15, 18, 19, 24 ) . In our study, Fc ␥ Ϫ / Ϫ mice had a transient surge of plasma cells in the spleen, while displaying a diminished rise in plasma cells in the BM and a reduced memory B cell response. In contrast, WT mice had a smaller population of splenic plasma cells and an increase in BM plasma cells after immunization and demonstrated B cell memory upon secondary challenge with antigen. Fc ␥ Ϫ / Ϫ mice produced significantly higher serum titers of specifi c antibody than WT mice and displayed class switching to IgG2a as well as IgG1. The increase in serum antipeptide and anti-DNA response appears to be an FcR-dependent phenomenon because Fc ␥ RI Ϫ / Ϫ immunized with MAP peptide showed a similar phenotype (Fig. S5 , available at http://www.jem.org/cgi/content/full/ jem.20070731/DC1). These features of the response may account for the increased glomerular dysfunction. Interestingly, antibodies from Fc ␥ Ϫ / Ϫ displayed less affi nity maturation. This serologic data were confi rmed by the demonstration of reduced GL-7 -positive cells in splenic B cells of Fc ␥ Ϫ / Ϫ mice (unpublished data) and less somatic mutation in antigen-specifi c hybridomas. Because some studies suggest that shortlived and long-lived plasma cells arise from completely separate precursors ( 25 ), we are currently studying the B cells responding to antigen in WT and Fc ␥ Ϫ / Ϫ mice to determine if the same clones are activated or whether the plasma cell precursors diff er between the strains.
DCs have previously been shown to mediate a critical function in B cell activation by transporting antigen from the periphery to T and B cells ( 26 ) . The altered B cell phenotype we observed in Fc ␥ Ϫ / Ϫ could also be traced to the infl uence of Fc ␥ Ϫ / Ϫ DCs and IL-12. Fc ␥ Ϫ / Ϫ DCs had a more mature phenotype and produced at least twofold more IL-12 than WT DCs. Several studies have established a role for IL-12 in B cell diff erentiation and function. IL-12 can induce plasma cell formation and B cell heavy chain class switching to IgG1 and IgG2a. The switch to IgG2 is IFN-␥ -dependent, whereas the promotion of diff erentiation to plasma cells and the switch to IgG1 does not require IFN-␥ ( 27 ) . Studies in human primary B cells have also shown that IL-12 up-regulates IL-12R ␤ 2 expression and IFN-␥ production by B cells, possibly allowing them to function as B eff ector cells and promote the activation of Th1 cells ( 28 ) . Notably, although IL-12 promotes short-lived plasma cells, perhaps in synergy with CD40L ( 27 ) , memory B cell diff erentiation occurs independently of IL-12 ( 22, 23 ) . In our study, when IL-12 was administered to WT mice, the mice responded to antigen immunization with the generation of more splenic plasma cells and fewer BM Adoptive transfer of B cells to muMT mice. 6-8-wk-old WT and Fc ␥ Ϫ / Ϫ mice were killed and total splenic B cells were purifi ed. Recipient MT mice were injected with 2 × 10 7 cells intravenously. 2 wk after transfer, both WT B cell -reconstituted and Fc ␥ Ϫ / Ϫ B cell -reconstituted muMT mice were immunized with MAP peptide as described. The antipeptide response from both groups was measured every 2 wk until 6 wk after immunization.
ELISAs. EIA/RIA high binding 96-well plates (Costar; Corning) were coated with 15 μ g/ml of the relevant peptide. For dsDNA ELISAs, plates were coated with 100 μ g/ml of sonicated calf thymus DNA (Sigma-Aldrich) that was fi ltered through a 0.45-μ m of nitrocellulose Millex-HA syringe fi lter (Millipore) to produce dsDNA. Plates were then blocked with 3% FCS or 5% milk. Alkaline phosphatase -conjugated anti -mouse total IgG or antimouse isotype-specifi c antibodies (SouthernBiotech) were used as secondary antibodies, and plates were developed with p -nitrophenyl phosphate (SigmaAldrich). OD was monitored at 405 nm.
ELISAs determining the apparent affi nity of peptide-specifi c antibodies were performed with the following modifi cation: sera were preincubated with varying concentrations of the relevant peptide before being loaded onto the antigen-coated plates. The K a was calculated as the reciprocal of the molar concentration of peptide inhibiting 50% of the binding ( 10 ).
Memory response. WT and Fc ␥ Ϫ / Ϫ mice were immunized and boosted as described above. Mice were bled every 2 wk to measure the antipeptide response in serum. After 8 wk, mice were challenged with 100 μ g MAP peptide in IFA, and blood was drawn 5 d later to analyze the antipeptide antibody response.
Immunohistochemistry of kidneys.
To determine glomerular IgG deposition, kidneys were obtained 13 wk after the initial immunization, fi xed in 10% paraformaldehyde, and embedded in paraffi n. Sections were blocked with 2% BSA and stained with biotinylated goat anti -mouse IgG. Alkaline phosphatase -labeled ABC reagent from the VECTASTAIN ABC kit (Vector Laboratories) was added. Sections were developed with 5-bromo-4-chloro-3-indolyl phosphate-toluidine salt and nitroblue tetrazolium chloride substrate (Invitrogen). Proteinuria was determined by color comparison using Multistix (Sigma-Aldrich).
Purifi cation of B cells. For B cell purifi cation, single-cell suspensions were prepared from splenocytes. After red blood cell lysis, cells were incubated with biotinylated anti-CD3, anti-CD11b, and anti-CD11c mAb (BD Biosciences), and B cells were isolated by negative selection with magnetic streptavidin-linked Dynabeads (Invitrogen). After depletion, > 90% of the remaining cells were B220 + by fl ow cytometry. All fl ow cytometry was performed on a FACSCalibur (Becton Dickinson) and analyzed with FlowJo Software (Tree Star, Inc.).
Purifi cation of T cells.
Mice were immunized in the right front and hind footpads with 100 μ g MAP peptide in 100 μ l of 1:1 PBS/CFA and in the left front and hind footpads with 100 μ l of 1:1 PBS/CFA alone (50 μ l/footpad). 1 wk later, left and right popliteal, axillary, and brachial lymph nodes were harvested, and a single cell suspension was prepared. Red blood cells were lysed, and cells at 2 × 10 7 cells/ml were incubated at 4 ° C for 30 min with supernatants from the following ATCC cell lines: TIB-120 (anti-A b,d,q and anti-E d,k ), HB-198 (anti-F4/80), and anti-B220 (BD Biosciences). Excess antibody was washed away and the cells were incubated with sheep anti -rat IgG Dynal/Dynal beads at 4 ° C for 30 min. T cells were isolated by magnetic bead depletion (Invitrogen) and were demonstrated by fl ow cytometry to be > 95% pure.
Peritoneal macrophages. To collect peritoneal macrophages, WT and Fc ␥ Ϫ / Ϫ mice were injected with 2 ml of 3% aged thioglycollate i.p. On day 4, mice were killed and macrophages were harvested in Hank ' s balanced salt solution. The purity of the cell population was assessed by staining with F480 antibody. All samples were > 85% F480 positive.
serum-free conditions also display an activated phenotype, which is, again, consistent with FcR engagement modulating DC function ( 26 ) . The activated phenotype was abrogated by addition of purifi ed IgG to the culture. Although ␥ chaincontaining Fc receptors have been demonstrated to be activating receptors, we speculated that engagement of these receptors may diminish the response to other activating receptors. Such reciprocal regulation of toll-like receptor 9 and IgE receptor signaling has already been demonstrated. Production of type I IFN by plasmacytoid DC is inhibited by preexposure of Fc RI to IgG ( 33 ) . These two signaling pathways counterregulate the development of Th1 and Th2 immune response. Park-Min et al. ( 34 ) recently demonstrated that immune complexes binding to Fc ␥ RIII suppresses LPSmediated IFN ␥ signaling in both human peripheral blood mononuclear cells derived macrophages and murine peritoneal macrophages. A recent publication reported that human peripheral monocyte-derived DC cultures exposed to immune complexes show diminished diff erentiation. Furthermore, in response to TLR-mediated stimulation, they produced less IL-12 ( 35 ) . This inhibition was mediated mainly through Fc ␥ RI but, to a lesser extent by Fc ␥ RII. Thus, there is precedent for an absence of engagement of activating FcRs permitting an enhanced response in other activation pathways. Although the mechanism for the altered function of Fc ␥ Ϫ / Ϫ DC requires further confi rmation, it is apparent that the difference in IL-12 production by DCs aff ects B cell diff erentiation. This study reports the fi rst in vivo manipulation that leads to diff erential formation of short-lived and long-lived plasma cells. Understanding how to modulate B cell diff erentiation will facilitate an appreciation of the role of both shortlived and long lived plasma cells. Furthermore, knowledge of the B cell phenotype responsible for the production of antiself or antimicrobial antibodies will help in the design of therapeutic strategies in autoimmune disease, as well as in optimizing vaccine development.
MATERIALS AND METHODS
Mice. 5 -10-wk-old female Fc ␥ Ϫ / Ϫ mice (Fcer1g(BALB/cBy)) on the BALB/c background and WT BALB/c mice were purchased from Taconics. The mice were housed in a specifi c pathogen-free barrier facility. IL12a Ϫ / Ϫ mice (C.129S1(B6)-Il12a tm1Jm /J) were purchased from Jackson ImmunoResearch Laboratories. IL-12a Ϫ / Ϫ mice were bred to Fc ␥ Ϫ / Ϫ mice for the generation of mice that were IL-12 p35 +/ Ϫ and Fc ␥ Ϫ / Ϫ . These studies were approved by the Institutional Animal Care and Use Committees of the Albert Einstein College of Medicine, Columbia University Medical Center, and Feinstein Institute for Medical Research.
Antigens. The peptides DWEYSVWLSN, linked to an eight-branched poly-lysine backbone (MAP peptide), and ADGSGGRDEMQASMWS were purchased from both Invitrogen and AnaSpec, Inc. The peptide ADGSGGRDEMQASMWS (10 -2) was conjugated to BSA with glutaraldehyde as previously described ( 12 ) . ter LPS treatment, and cytokines were assayed in the culture supernatant using anti -mouse cytokine ELISA kits. Cytokine concentrations were determined based on standard curves.
For real-time PCR, total RNA was prepared from BMDCs either unstimulated or LPS-stimulated for 4 h using TRIzol Reagent (Invitrogen). 1 μ g DNA-free RNA was reverse transcribed to cDNA using SuperScript III First-Strand Synthesis system for RT-PCR (Invitrogen). Real-time PCR was performed with TaqMan Universal PCR Master Mix (Applied Biosystem) on an iCycler iQ instrument (Bio-Rad Laboratories). Amplifi cation conditions were 50 ° C for 2 min and 95 ° C for 10 min, followed by 40 cycles of 95 ° C for 15 s and 60 ° C for 1 min. Primers for 18s ribosomal RNA, IL12a, IL-12b, and AID were purchased from Applied Biosystems. Relative expression was determined using the following formula: relative expression = In vivo cytokine production by splenic DCs. BALB/c WT or Fc ␥ Ϫ / Ϫ mice were immunized with 100 μ g MAP peptide in CFA i.p. Each group of mice was killed on either day 1 or 3 after immunization. Splenic DCs were purifi ed as described in Materials and methods and cultured in RPMI 1640 supplemented with 10% FCS for 16 h. Supernatant was collected and cytokine production was analyzed by ELISA.
BMDC and B cell coculture assays. BMDCs were stained with antiCD11c PE (BD Biosciences) and sorted on a MoFlo Cell Sorter (Dako). More than 95% of the sorted cells were CD11c + . Mature BMDCs, irradiated with 1,500 rads, were cultured with 5 × 10 4 B cells in triplicate in RPMI with 10% FCS in the presence of 20 μ g/ml of purifi ed anti-CD40 antibody (BD Biosciences). In some assays, 10 μ g/ml of purifi ed anti -IL-12 antibody (BD Biosciences) was added to the culture. 5 d later, 1 μ Ci of 3 H-thymidine was added to each well for 8 h, and the incorporated radioactivity was determined. To block the secretion of IL-12 during the coculture, siRNA (siRNA ID#: 102773l; Ambion) targeting the IL-12a gene was transfected to BMDC according to the manufacturer ' s protocol. In brief, irradiated BMDCs cultured from both WT and Fc ␥ Ϫ / Ϫ mice were transfected with 1 and 10 μ M of anti -IL-12a specifi c or negative control siRNA by siPORT NeoFX (Ambion). The next day, siRNA/transfection agents were removed and 5 × 10 4 splenic B cells were added to the culture.
T cell proliferation. T cells were purifi ed from lymph nodes of MAP peptide -primed WT or Fc ␥ Ϫ / Ϫ mice as described in Materials and methods. BMDCs were prepared from nonimmunized WT and Fc ␥ Ϫ / Ϫ mice and pulsed with MAP peptide on day 6 of culture. On day 7, 1 -3 × 10 5 primed T cells were cocultured in triplicate for 72 h with 5 × 10 4 irradiated DCs. Cells were pulsed with 0.5 μ Ci of 3 H-thymidine for the last 8 h. Cells were harvested, and the incorporated radioactivity was counted.
Analysis of V ␤ usage and cytokine ELISAs. Cells from the draining lymph nodes of naive mice or mice immunized 7 d earlier with MAP peptide in CFA or CFA alone were harvested and plated at 3 × 10 6 cells/ml in IMDM supplemented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin, 100 μ g/ml streptomycin, and 50 μ M ␤ -mercaptoethanol in the presence of 50 μ g/ml MAP peptide. 7 d later, the cultures were supplemented with 50 U/ml of recombinant human IL-2 (Invitrogen) and 3 × 10 6 RBC-depleted irradiated (1,500 rads) splenocytes/ml along with fresh medium. 14 d after the initial culture, cells were collected. 2 × 10 5 cells were stained with 100 μ l of 1 μ g/ml CD4-PE in 2% FCS/PBS for 30 min on ice and then stained for the various V ␤ chains using FITC-labeled antibodies. All labeled antibodies were obtained from BD Biosciences and data were acquired using a FACScan (Becton Dickinson). Peptide-specifi c T cells were identifi ed by comparison of lymph node cultures from mice immunized with MAP peptide in CFA to those from mice immunized with CFA alone. Little proliferation was detected in the latter with 3 -4 times as many live cells found in the peptide-specifi c cultures compared with the CFA controls.
Purifi cation of DCs. BMDCs were generated according to a previously described protocol ( 36 ) . In brief, BM was harvested and red blood cells were lysed. T cells and B cells were depleted by incubating the cells with the ATCC supernatants TIB-120, TIB-211 (anti-CD8), TIB 207 (anti-CD4), and TIB-146 (anti-B220) in the presence of rabbit complement (Pel-Freez Biologicals). The remaining cells were cultured in RPMI 1640 with 5% FCS and GM-CSF-containing supernatant from J558L cells (gift of the laboratory of R. Steinman, The Rockefeller University, New York, NY). Cells were given fresh medium on days 2 and 4. On day 6, the nonadherent cells were collected and were incubated overnight in medium with or without 50 ng/ml LPS from Escherichia coli serotype 055:B5 (Sigma-Aldrich). To further deplete monocytes, the cells were plated for 2 h, and nonadherent cells were collected. The depleted cells were > 85% CD11c + by fl ow cytometry.
To purify splenic DCs, a modifi cation of the original method of Steinman et al. ( 37 ) was used. In brief, spleen cell suspensions were prepared by digestion with 400 U/ml collagenase D at 37 ° C for 25 min, followed by 0.5 M EDTA. Total splenocytes were washed and resuspended in 30% BSA. Icecold PBS was loaded on top of the mixture. DCs were collected from the interface after centrifugation at 2,200 rpm for 30 min. To increase the purity of DCs, we used negative selection methods with a mouse DC enrichment set (BD Biosciences). After two steps of purifi cation, the purity was measured by fl ow cytometry and ‫ف‬ 75 -80% of cells were CD11c + .
Enumeration of plasma cells. Antigen-specifi c plasma cells were enumerated in the spleen and BM of femurs by performing peptide-specifi c ELISPOT assays. For plasma cells in the spleen, MAP peptide -immunized mice were killed and splenocytes were harvested. Red blood cells were lysed, and the splenocytes were added to plates coated with 10 μ g/ml MAP peptide and blocked with 10% FCS. The plates were centrifuged at 1,000 rpm for 5 min and incubated overnight at 37 ° C. The next day, splenocytes were washed stringently and biotinylated goat anti -mouse IgG (SouthernBiotech) was added for 2 h at 37 ° C. Washed plates were incubated with streptavidin-alkaline phosphatase (SouthernBiotech) for 2 h and developed with 5-bromo-4-chloro-3-indolyl phosphate p -toluidine salt (Sigma-Aldrich). Spots were counted manually using a dissecting microscope. To enumerate plasma cells in the BM, CD138 + cells were identifi ed by fl ow cytometry, and CD138 + cells from WT and Fc ␥ Ϫ / Ϫ mice were sorted on a FACSAria and plated for MAP peptide -specifi c ELISPOT analysis.
Spleen histology. Spleens were harvested on days 0, 4, 8, 12, and 16 after immunization and snap frozen in Tissue-Tek O.C.T. compound (Sakura Finetek). Sections were incubated with anti -mouse B220-FITC and CD138-PE, or B220-PE and PNA-FITC, and were visualized using a fl uorescent microscope (AxioCam II; Carl Zeiss, Inc.).
AID expression in germinal center B cells. Expression of AID gene was measured in purifi ed germinal center B cells. WT and Fc ␥ Ϫ / Ϫ mice were immunized with 100 μ g of MAP peptide in CFA on day 0. On day 10, mice were killed and splenic B cells were purifi ed by depletion of non-B cells: splenocytes were incubated with biotinylated anti-CD43, anti-CD11c, and anti-CD90.2 (BD Biosciences) and bound cells were removed by streptavidin-conjugated magnetic beads. B220 and PNA double-positive cells were isolated on a FACSAria as germinal center B cells, and B220-positive and PNA-negative fractions were collected as control cells. AID expression was measured by real-time PCR using total RNA from each fraction. Gene-specifi c primers for AID were purchased from TaqMan, and real-time PCR was performed as described in Materials and methods.
Analysis of DC phenotype and cytokine secretion. For cytokine secretion, intracellular fl ow cytometry was performed. LPS-treated or untreated BMDCs were cultured at 5 × 10 5 /ml with 10 μ g/ml brefeldin A (Sigma-Aldrich) for 5 h. The cells were then stained with anti-CD11c PE (BD Biosciences) and fi xed in 2% paraformaldehyde for 10 min before staining with anti -IL-12 APC or anti -IL-10 APC in 0.3% saponin for 30 min. For cytokine analysis by ELISA, 10 6 BMDCs were cultured for an additional 24 h af-
